These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19326913)

  • 1. Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery.
    Elmouelhi N; Aich U; Paruchuri VD; Meledeo MA; Campbell CT; Wang JJ; Srinivas R; Khanna HS; Yarema KJ
    J Med Chem; 2009 Apr; 52(8):2515-30. PubMed ID: 19326913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regioisomeric SCFA attachment to hexosamines separates metabolic flux from cytotoxicity and MUC1 suppression.
    Aich U; Campbell CT; Elmouelhi N; Weier CA; Sampathkumar SG; Choi SS; Yarema KJ
    ACS Chem Biol; 2008 Apr; 3(4):230-40. PubMed ID: 18338853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells.
    Campbell CT; Aich U; Weier CA; Wang JJ; Choi SS; Wen MM; Maisel K; Sampathkumar SG; Yarema KJ
    J Med Chem; 2008 Dec; 51(24):8135-47. PubMed ID: 19053749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological, Physiochemical, and Drug-Relevant Biological Properties of Short Chain Fatty Acid Hexosamine Analogues Used in Metabolic Glycoengineering.
    Saeui CT; Liu L; Urias E; Morrissette-McAlmon J; Bhattacharya R; Yarema KJ
    Mol Pharm; 2018 Mar; 15(3):705-720. PubMed ID: 28853901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular and intracellular esterase processing of SCFA-hexosamine analogs: implications for metabolic glycoengineering and drug delivery.
    Mathew MP; Tan E; Shah S; Bhattacharya R; Adam Meledeo M; Huang J; Espinoza FA; Yarema KJ
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6929-33. PubMed ID: 23041156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogs.
    Aich U; Meledeo MA; Sampathkumar SG; Fu J; Jones MB; Weier CA; Chung SY; Tang BC; Yang M; Hanes J; Yarema KJ
    Glycoconj J; 2010 May; 27(4):445-59. PubMed ID: 20458533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.
    Cohen J; Chen Z; Lu SL; Yang XP; Arun P; Ehsanian R; Brown MS; Lu H; Yan B; Diallo O; Wang XJ; Van Waes C
    Cancer Res; 2009 Apr; 69(8):3415-24. PubMed ID: 19351843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene induction by glycyrol to apoptosis through endonuclease G in tumor cells and prediction of oncogene function by microarray analysis.
    Lee S; Oh HM; Lim WB; Choi EJ; Park YN; Kim JA; Choi JY; Hong SJ; Oh HK; Son JK; Lee SH; Kim OJ; Choi HR; Jun CD
    Anticancer Drugs; 2008 Jun; 19(5):503-15. PubMed ID: 18418217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity.
    Lu S; Becker KA; Hagen MJ; Yan H; Roberts AL; Mathews LA; Schneider SS; Siegelmann HT; MacBeth KJ; Tirrell SM; Blanchard JL; Jerry DJ
    Endocrinology; 2008 Oct; 149(10):4809-20. PubMed ID: 18556351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes.
    Saeui CT; Nairn AV; Galizzi M; Douville C; Gowda P; Park M; Dharmarha V; Shah SR; Clarke A; Austin M; Moremen KW; Yarema KJ
    PLoS One; 2018; 13(5):e0195812. PubMed ID: 29847599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the metabolic flux and apoptotic effects of O-hydroxyl- and N-acyl-modified N-acetylmannosamine analogs in Jurkat cells.
    Kim EJ; Sampathkumar SG; Jones MB; Rhee JK; Baskaran G; Goon S; Yarema KJ
    J Biol Chem; 2004 Apr; 279(18):18342-52. PubMed ID: 14966124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global gene expression changes underlying Stachybotrys chartarum toxin-induced apoptosis in murine alveolar macrophages: evidence of multiple signal transduction pathways.
    Wang H; Yadav JS
    Apoptosis; 2007 Mar; 12(3):535-48. PubMed ID: 17186382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
    Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
    Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of N-acetylmannosamine (ManNAc) analogue-resistant cell lines as improved hosts for sialic acid engineering applications.
    Kim EJ; Jones MB; Rhee JK; Sampathkumar SG; Yarema KJ
    Biotechnol Prog; 2004; 20(6):1674-82. PubMed ID: 15575698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid.
    Mathew MP; Tan E; Labonte JW; Shah S; Saeui CT; Liu L; Bhattacharya R; Bovonratwet P; Gray JJ; Yarema KJ
    Chembiochem; 2017 Jul; 18(13):1204-1215. PubMed ID: 28218815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway.
    Dong G; Loukinova E; Chen Z; Gangi L; Chanturita TI; Liu ET; Van Waes C
    Cancer Res; 2001 Jun; 61(12):4797-808. PubMed ID: 11406555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting glycosylation pathways and the cell cycle: sugar-dependent activity of butyrate-carbohydrate cancer prodrugs.
    Sampathkumar SG; Jones MB; Meledeo MA; Campbell CT; Choi SS; Hida K; Gomutputra P; Sheh A; Gilmartin T; Head SR; Yarema KJ
    Chem Biol; 2006 Dec; 13(12):1265-75. PubMed ID: 17185222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerations.
    Almaraz RT; Aich U; Khanna HS; Tan E; Bhattacharya R; Shah S; Yarema KJ
    Biotechnol Bioeng; 2012 Apr; 109(4):992-1006. PubMed ID: 22068462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of inducible heparanase gene transcription in activated T cells by early growth response 1.
    de Mestre AM; Khachigian LM; Santiago FS; Staykova MA; Hulett MD
    J Biol Chem; 2003 Dec; 278(50):50377-85. PubMed ID: 14522979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.